Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-03-17 4:45 pm Sale | 2025-03-14 | 13D | Amneal Pharmaceuticals, Inc. AMRX | Patel Tushar Bhikhubhai | 48,578,209 15.700% | -5,000,000 (-9.33%) | Filing History |
| 2025-02-10 08:59 am Sale | 2024-12-31 | 13G | Amneal Pharmaceuticals, Inc. AMRX | UBS Group AG | 0 0.000% | -21,491,881 (Position Closed) | Filing History |
| 2025-01-23 5:49 pm Sale | 2024-11-13 | 13D | Amneal Pharmaceuticals, Inc. AMRX | Patel Dipan | 23,828,992 7.700% | -3,076,081 (-11.43%) | Filing History |
| 2024-11-14 4:11 pm Sale | 2024-09-30 | 13G | Amneal Pharmaceuticals, Inc. AMRX | Mahesh Akram | 26,856,413 8.800% | -3,528,356 (-11.61%) | Filing History |
| 2024-10-31 6:51 pm Unchanged | 2024-10-29 | 13D | Amneal Pharmaceuticals, Inc. AMRX | Patel Chirag K. | 21,835,007 7.100% | 0 (Unchanged) | Filing History |
| 2024-10-30 11:04 am Purchase | 2024-09-30 | 13G | Amneal Pharmaceuticals, Inc. AMRX | UBS Group AG | 21,491,881 6.900% | 21,491,881 (New Position) | Filing History |
| 2024-05-13 4:15 pm Unchanged | 2024-05-09 | 13D | Amneal Pharmaceuticals, Inc. AMRX | Patel Tushar Bhikhubhai | 53,578,209 17.400% | 0 (Unchanged) | Filing History |
| 2024-04-24 06:03 am Sale | 2024-03-31 | 13G | Amneal Pharmaceuticals, Inc. AMRX | Fosun International Ltd | 9,200,603 3.000% | -9,207,053 (-50.02%) | Filing History |
| 2024-02-13 4:58 pm Purchase | 2023-12-29 | 13G | Amneal Pharmaceuticals, Inc. AMRX | The Vanguard Group | 13,642,387 4.450% | 594,319 (+4.55%) | Filing History |
| 2024-01-05 4:09 pm Purchase | 2024-01-01 | 13G | Amneal Pharmaceuticals, Inc. AMRX | Mahesh Akram | 30,384,769 9.900% | 30,384,769 (New Position) | Filing History |
| 2024-01-03 4:30 pm Sale | 2024-01-01 | 13D | Amneal Pharmaceuticals, Inc. AMRX | Patel Gautam | 2,025,454 0.070% | -31,859,952 (-94.02%) | Filing History |
| 2023-12-12 06:04 am Unchanged | 2023-11-07 | 13G | Amneal Pharmaceuticals, Inc. AMRX | Fosun International Ltd | 18,407,656 6.000% | 0 (Unchanged) | Filing History |
| 2023-12-01 4:15 pm Purchase | 2021-12-01 | 13D | Amneal Pharmaceuticals, Inc. AMRX | Patel Gautam | 33,885,406 11.100% | 3,073,298 (+9.97%) | Filing History |
| 2023-11-08 5:07 pm Unchanged | 2023-11-07 | 13D | Amneal Pharmaceuticals, Inc. AMRX | Patel Chirag K. | 21,835,007 7.100% | 0 (Unchanged) | Filing History |
| 2023-11-08 5:05 pm Unchanged | 2023-11-07 | 13D | Amneal Pharmaceuticals, Inc. AMRX | Patel Dipan | 26,905,073 8.800% | 0 (Unchanged) | Filing History |
| 2023-11-08 5:03 pm Purchase | 2023-11-07 | 13D | Amneal Pharmaceuticals, Inc. AMRX | Patel Gautam | 30,812,108 10.000% | 17,497,336 (+131.41%) | Filing History |
| 2023-11-08 4:59 pm Unchanged | 2023-11-07 | 13D | Amneal Pharmaceuticals, Inc. AMRX | Patel Chintu | 25,318,839 8.300% | 0 (Unchanged) | Filing History |
| 2023-11-08 4:55 pm Unchanged | 2023-11-07 | 13D | Amneal Pharmaceuticals, Inc. AMRX | Patel Tushar Bhikhubhai | 53,578,209 17.500% | 0 (Unchanged) | Filing History |
| 2023-10-17 7:32 pm Unchanged | 2023-10-16 | 13D | Amneal Pharmaceuticals, Inc. AMRX | Patel Dipan | 26,905,073 14.900% | 0 (Unchanged) | Filing History |
| 2023-10-17 7:31 pm Purchase | 2023-10-16 | 13D | Amneal Pharmaceuticals, Inc. AMRX | Patel Chirag K. | 21,835,007 14.160% | 534,503 (+2.51%) | Filing History |